Surgalign Holdings Inc (SRGA)
5.25
+0.01 (+0.19%)
USD |
NASDAQ |
May 26, 16:00
5.00
-0.25 (-4.76%)
Pre-Market: 20:00
Surgalign Holdings Cash from Operations (Quarterly): -19.14M for March 31, 2022
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2022 | -19.14M |
| December 31, 2021 | -10.18M |
| September 30, 2021 | 4.536M |
| June 30, 2021 | -31.62M |
| March 31, 2021 | -14.53M |
| December 31, 2020 | -15.37M |
| September 30, 2020 | -58.08M |
| June 30, 2020 | -21.10M |
| March 31, 2020 | 6.516M |
| December 31, 2019 | 3.048M |
| September 30, 2019 | 0.435M |
| June 30, 2019 | 2.618M |
| March 31, 2019 | -15.56M |
| December 31, 2018 | 6.245M |
| September 30, 2018 | 1.629M |
| June 30, 2018 | 10.83M |
| March 31, 2018 | -1.449M |
| December 31, 2017 | 8.646M |
| September 30, 2017 | -13.47M |
| June 30, 2017 | 1.036M |
| March 31, 2017 | 9.577M |
| December 31, 2016 | 5.289M |
| September 30, 2016 | -3.175M |
| June 30, 2016 | 6.786M |
| March 31, 2016 | 6.423M |
| Date | Value |
|---|---|
| December 31, 2015 | 6.573M |
| September 30, 2015 | -4.294M |
| June 30, 2015 | 5.711M |
| March 31, 2015 | 1.006M |
| December 31, 2014 | 5.43M |
| September 30, 2014 | 2.149M |
| June 30, 2014 | 2.622M |
| March 31, 2014 | -3.307M |
| December 31, 2013 | 7.416M |
| September 30, 2013 | -7.086M |
| June 30, 2013 | 3.279M |
| March 31, 2013 | -8.063M |
| December 31, 2012 | 3.504M |
| September 30, 2012 | 8.119M |
| June 30, 2012 | 4.815M |
| March 31, 2012 | 4.365M |
| December 31, 2011 | 5.353M |
| September 30, 2011 | 7.321M |
| June 30, 2011 | 8.613M |
| March 31, 2011 | 6.48M |
| December 31, 2010 | 26.44M |
| September 30, 2010 | -0.831M |
| June 30, 2010 | 2.458M |
| March 31, 2010 | 1.318M |
| December 31, 2009 | -5.749M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-58.08M
Minimum
Sep 2020
10.83M
Maximum
Jun 2018
-7.748M
Average
-0.507M
Median
Cash from Operations (Quarterly) Benchmarks
| PolarityTE Inc | -6.041M |
| Tonix Pharmaceuticals Holding Corp | -31.05M |
| AIM ImmunoTech Inc | -2.758M |
| NovaBay Pharmaceuticals Inc | -2.057M |
| Protalix BioTherapeutics Inc | -5.829M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -1.342M |
| Cash from Financing (Quarterly) | 13.64M |
| Free Cash Flow | -69.34M |
| Free Cash Flow Per Share (Quarterly) | -3.465 |
| Free Cash Flow to Equity (Quarterly) | -20.53M |
| Free Cash Flow to Firm (Quarterly) | -20.44M |
| Free Cash Flow Yield | -278.6% |